FOXC2  and  CLIP4 : a potential biomarker for  synchronous metastasis of &#x2264;7-cm clear cell renal cell carcinomas

Jinwoo Ahn; Kyung Seok Han; Jun Hyeok Heo; Duhee Bang; You Hyun Kang; Hyun A. Jin; Sung Joon Hong; Ji Hyun Lee; Won Sik Ham

doi:10.18632/oncotarget.9842

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

FOXC2 and CLIP4 : a potential biomarker for synchronous metastasis of ≤7-cm clear cell renal cell carcinomas

Jinwoo Ahn _, Kyung Seok Han, Jun Hyeok Heo, Duhee Bang, You Hyun Kang, Hyun A. Jin, Sung Joon Hong, Ji Hyun Lee and Won Sik Ham

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2016; 7:51423-51434. https://doi.org/10.18632/oncotarget.9842

Metrics: PDF 2108 views | HTML 2181 views | ?

Abstract

Jinwoo Ahn1,*, Kyung Seok Han2,*, Jun Hyeok Heo3, Duhee Bang1, You Hyun Kang3,4, Hyun A. Jin3,4, Sung Joon Hong3, Ji Hyun Lee5, Won Sik Ham3

1Department of Chemistry, Yonsei University, Seoul, Korea

2Department of Urology, Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, Korea

3Department of Urology and Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea

4Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea

5Department of Clinical Pharmacology and Therapeutics, College of Medicine, Kyung Hee University, Seoul, Korea

*These authors have contributed equally to this work

Correspondence to:

Won Sik Ham, email: [email protected]

Ji Hyun Lee, email: [email protected],kr

Keywords: clear cell renal cell carcinoma (ccRCC), whole exome sequencing, metastasis, FOXC2, CLIP4

Received: February 10, 2016 Accepted: May 20, 2016 Published: June 06, 2016

ABSTRACT

Renal cell carcinomas (RCC) smaller than 7-cm are heterogeneous and exhibit metastatic potential in approximately 15% of cases. Although large-scale characterization of mutations in clear cell RCC (ccRCC), the most common RCC subtype, has been established, the genetic alterations related to ≤7-cm ccRCCs undergoing synchronous metastasis are poorly understood. To discover biomarkers that can be used to estimate the risk of synchronous metastasis in these ccRCC patients, we performed whole exome sequencing on the formalin-fixed paraffin-embedded (FFPE) samples of 10 ccRCC patients with ≤7-cm tumors and synchronous metastasis and expanded our study using The Cancer Genome Atlas (TCGA) ccRCC dataset (n = 201). Recurrent mutations were selected according to functional prediction and statistical significance. Mutations in three candidate genes, RELN (1 out of 10), FOXC2 (1 out of 10), and CLIP4 (2 out of 10) were found in expanded analysis using a TCGA cohort. Furthermore, siRNA-mediated target gene knockdown (FOXC2 and CLIP4) and overexpression (RELN) assays showed that FOXC2 and CLIP4 significantly increased cell migration and viability in ccRCCs. Our study demonstrated that FOXC2 and CLIP4 activity correlates to the presence of ≤7-cm ccRCCs with synchronous metastasis and may be potential molecular predictors of synchronous metastasis of ≤7-cm ccRCCs.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 9842

Publication Alerts

Research Papers:

FOXC2 and CLIP4 : a potential biomarker for synchronous metastasis of ≤7-cm clear cell renal cell carcinomas

Abstract